These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


608 related items for PubMed ID: 24357067

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
    Berghmans N, Heremans H, Li S, Martens E, Matthys P, Sorokin L, Van Damme J, Opdenakker G.
    J Neuroinflammation; 2012 Oct 25; 9():243. PubMed ID: 23095573
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
    Luz A, Fainstein N, Einstein O, Ben-Hur T.
    Exp Neurol; 2015 Nov 25; 273():234-42. PubMed ID: 26342755
    [Abstract] [Full Text] [Related]

  • 25. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE.
    Moreno M, Bannerman P, Ma J, Guo F, Miers L, Soulika AM, Pleasure D.
    J Neurosci; 2014 Jun 11; 34(24):8175-85. PubMed ID: 24920622
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.
    Stoolman JS, Duncker PC, Huber AK, Giles DA, Washnock-Schmid JM, Soulika AM, Segal BM.
    J Neuroinflammation; 2018 Jul 16; 15(1):208. PubMed ID: 30012158
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
    Papaneophytou CP, Georgiou E, Karaiskos C, Sargiannidou I, Markoullis K, Freidin MM, Abrams CK, Kleopa KA.
    Glia; 2018 Dec 16; 66(12):2589-2603. PubMed ID: 30325069
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.
    Crocker SJ, Whitmire JK, Frausto RF, Chertboonmuang P, Soloway PD, Whitton JL, Campbell IL.
    Am J Pathol; 2006 Dec 16; 169(6):2104-16. PubMed ID: 17148673
    [Abstract] [Full Text] [Related]

  • 35. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
    Lee E, Chanamara S, Pleasure D, Soulika AM.
    J Neuroinflammation; 2012 Jan 16; 9():7. PubMed ID: 22248039
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS, Huston K, Shaw M, Tse HY, Raine CS.
    Lab Invest; 1994 Nov 16; 71(5):671-9. PubMed ID: 7526038
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis.
    Mathisen PM, Kawczak JA, Yu M, Johnson JM, Tuohy VK.
    J Neurosci Res; 2001 Jun 01; 64(5):542-51. PubMed ID: 11391709
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 31.